Managed Healthcare Executive Newsletter

To view this email as a web page, click here.

Legislating Medicare and Medicaid Drug Plans

With the proposed rebate rule now withdrawn, what will Congress do to help curb drug spend?

How can payers appropriately plan and manage benefit coverage with so many expensive specialty drugs coming down the pipeline?

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.